Profitability Margin Analysis Delights Active Investors: ICICI Bank Limited (NYSE:IBN), Grupo Financiero Santander Mexico (NYSE:BSMX)

ICICI Bank Limited (NYSE:IBN) kept active in profitability ratio analysis, on current situation shares price an ascending -1.13% to $7.86. The total volume of 5.6 Million shares held in the session, while on average its shares change hands 9318.81 shares.

Efficiency Evaluation in Focus

The returns on investment very popular metric among passive investors, it stands at 4.50%, when it lies in positive figure than security is feasible for investment or goes for higher ROI stocks. To see the other side of picture, profit margin of IBN stands at 0.00%; that indicates a firm actually every dollar of sales keeps in earnings.  Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm. It has forward price to earnings ratio of 15.98, and price to earnings ratio calculated as 25.11. The price to earnings growth ration calculated as 1.14.

To stick with focus on profitability valuation, Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) also listed in significant eye catching mover, BSMX attains returns on investment ratio of 20.70%, which suggests it’s viable on security that has lesser ROI.

To strengthen this concept we can use profit margin, which is standing at positive 20.80%, and it is providing insight view about a variety of aspects of a firm’s financial performance. The operating profit margin can be giving more focus view that is 41.50%. Turns back to returns ratios, the co’s returns on assets calculated as 20.70%; that gives an idea as to how efficient management is at using its assets to generate earnings. Finally yet importantly, returns on equity stands at 13.10%.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 5.40%, and looking further price to next year’s EPS is 4.93%. While take a short look on price to sales ratio, that was 2.90 and price to earning ration of 13.31 attracting passive investors.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *